Search Results - "Neff, G.W."

The Role of Coronary Calcium Score in the Risk Assessment of Liver Transplant Candidates by Kemmer, N, Case, J, Chandna, S, Neff, G.W

“…Abstract Background Coronary artery disease (CAD) is a common cause of morbidity and mortality in liver transplant (LT) recipients. To date there is no…”
Get full text

Alpha-1-Antitrypsin Deficiency: Outcomes After Liver Transplantation by Kemmer, N, Kaiser, T, Zacharias, V, Neff, G.W

“…Abstract Alpha-1-antitrypsin deficiency (AAT) is the most common inherited metabolic disease leading to liver transplantation (LT) in children and adults. The…”
Get full text

Social Determinants of Orthotopic Liver Transplantation Candidacy: Role of Patient-Related Factors by Kemmer, N, Alsina, A, Neff, G.W

“…Abstract Introduction Eligibility for orthotopic liver transplantation (OLT) requires careful selection of the best possible candidate. The aim of this study…”
Get full text

Orthotopic Liver Transplantation in a Multiethnic Population: Role of Spatial Accessibility by Kemmer, N, Alsina, A, Neff, G.W

“…Abstract Introduction Access to orthotopic liver transplantation (OLT) varies among different ethnic groups. The aim of this study was to determine if distance…”
Get full text

Outcomes in Adult and Pediatric Liver Transplantation Among Various Ethnic Groups by Neff, G.W, Kemmer, N, Kaiser, T, Zacharias, V, Majoras, N, Safdar, K

“…Abstract Background The reported patient and graft survivals among adults post–orthotopic liver transplantation (OLT) are variable, with an apparent…”
Get full text

Long-term Analysis of Primary Nonfunction in Liver Transplant Recipients by Kemmer, N, Secic, M, Zacharias, V, Kaiser, T, Neff, G.W

“…Abstract Long-term allograft and patient survival following liver transplantation continues to improve with the development of new surgical techniques and…”
Get full text

Refractory Ascites After Liver Transplantation: An Analysis of 1058 Liver Transplant Patients at a Single Center by Nishida, S., Gaynor, J. J., Nakamura, N., Butt, F., Illanes, H. G., Kadono, J., Neff, G. W., Levi, D. M., Moon, J. I., Selvaggi, G., Kato, T., Ruiz, P., Tzakis, A. G., Madariaga, J. R.

“…A retrospective study of 1058 liver transplant recipients was performed to determine: (i) the incidence, etiology, timing, clinical features and treatment of…”
Get full text

Intestinal Schistosomiasis Following Orthotopic Liver Transplantation: A Case Report by Ahmed, K, Safdar, K, Kemmer, N, Atiq, M, Wang, J, Neff, G.W

“…Abstract Recent World Health Organization (WHO) reports estimate that 500–600 million people worldwide are at risk of schistosomiasis. In areas of high…”
Get full text

Liver transplant for the septuagenarians: importance of patient selection by Safdar, K, Neff, G.W, Montalbano, M, Meyer, D, O'Brien, C, Yamashiki, N, Schiff, E, Tzakis, A

“…With the increasing success of liver transplantation (OLT), more patients above 70 years of age are being considered for OLT. There is not enough data about…”
Get full text

Sirolimus Conversion Regimen Versus Continued Calcineurin Inhibitors in Liver Allograft Recipients: A Randomized Trial by Abdelmalek, M. F., Humar, A., Stickel, F., Andreone, P., Pascher, A., Barroso, E., Neff, G. W., Ranjan, D., Toselli, L. T., Gane, E. J., Scarola, J., Goldberg‐Alberts, R., Maller, E. S., Lo, C.‐M.

“…A large prospective, open‐label, randomized trial evaluated conversion from calcineurin inhibitor (CNI)‐ to sirolimus (SRL)‐based immunosuppression for…”
Get full text

Analysis of Hospitalizations Comparing Rifaximin Versus Lactulose in the Management of Hepatic Encephalopathy by Neff, G.W., Kemmer, N., Zacharias, V.C., Kaiser, T., Duncan, C., McHenry, R., Jonas, M., Novick, D., Williamson, C., Hess, K., Thomas, M., Buell, J.

“…Patients with end-stage liver disease often develop hepatic encephalopathy. The loss in cognitive abilities results in marked economic loss to the patient and…”
Get full text

Biomarkers, imaging and safety in resmetirom 52 week non-cirrhotic NASH phase 3 clinical trial, completed open-label arm of maestro-NAFLD-1 by Harrison, Dr. S.A., Mangia, Dr. A., Lasierra-Resa, Dr. P., Cubberley, Ms. S., Taub, Dr. R.A., Neff, Dr. G.W., Alkhouri, Dr. Naim, Bashir, Dr. Mustafa

Get full text

Ten years of sirolimus therapy in orthotopic liver transplant recipients by Neff, G.W, Montalbano, M, Tzakis, A.G

“…Sirolimus therapy has been used in orthotopic liver transplant (OLT) recipients diagnosed with a variety of diseases; chronic graft rejection (CR), calcineurin…”
Get full text

Fulminant Hepatic Failure from Herpes Simplex Virus: Post Liver Transplantation Acyclovir Therapy and Literature Review by Montalbano, M., Slapak-Green, G.I., Neff, G.W.

“…Herpes simplex virus (HSV) is seen throughout the world and can be treated with acyclovir. We present a case of fulminant hepatic failure (FHF) as a result of…”
Get full text

505 Conversion of liver transplant recipients with hepatitis B virus from hepatitis B immune globulin (HBIG) and lamivudine (LAM) to adefovir dipivoxil (ADV) and LAM by Neff, G.W., Zacharias, V.C., Alonzo, M., Kenner, N., Weber, E., Kaiser, T.E., Safdar, K., Rideman, E., Thomas, M., Martin, J., Rudich, S., Tevar, A., Buell, J.

Get full text

Sirolimus therapy in orthotopic liver transplant recipients with calcineurin inhibitor related chronic renal insufficiency by Neff, G.W, Montalbano, M, Slapak-Green, G, Meyer, D, Berney, T, Safdar, K, Schiff, E.R, Tzakis, A.G

“…Calcineurin inhibitor-related renal toxicity affects patient and graft survival in transplant recipients. Our clinical experience has revealed sirolimus to be…”
Get full text

Prostate Cancer Prior to Solid Organ Transplantation: The Israel Penn International Transplant Tumor Registry Experience by Woodle, E.S., Gupta, M., Buell, J.F., Neff, G.W., Gross, T.G., First, M.R., Hanaway, M.J., Trofe, J.

“…Prostate adenocarcinoma (PCA) is the second leading cause of cancer-related deaths in men, and with routine prostrate specific antigen (PSA) screening, is…”
Get full text

The wide spectrum of sirolimus side effects by Montalbano, M., Neff, G.W., Yamashiki, N., Mayer, D., Nery, J., Weppler, D., Schiff, E.R., Tzakis, A.G.

Get full text

The Importance of Clinical Parameters When Differentiating Cholestatic Hepatitis C Virus From Allograft Rejection by Neff, G.W., Shire, N., Ruiz, P., O’Brien, C., Garcia, M., dela Garza, J., Rudich, S.R., Reddy, K. Rajender

“…The exact cause and appropriate treatment for cholestasis following liver transplantation in recipients with hepatitis C virus recurrence (RHCV) are difficult…”
Get full text

Liver transplantation in HCV-infected patients: An 8 year single center experience by Nery, J.R., Neff, G.W., Montalbano, M., Nery, C., Safdar, K., Britto, S., Kato, T., Levi, D., Nishida, S., Madariaga, J., Bejerano, P., Ruitz, P., Schiff, E.R., Tzakis, A.G.

Get full text